132 related articles for article (PubMed ID: 22259737)
1. Continence rate and oncological feasibility after total transurethral resection of the prostate as an alternative therapy for the treatment of prostate cancer: a pilot study.
Jeong HJ; Kwon DD
Int Neurourol J; 2011 Dec; 15(4):222-7. PubMed ID: 22259737
[TBL] [Abstract][Full Text] [Related]
2. [Radical transurethral resection of the prostate. An alternative therapy for the treatment of prostate cancer].
Reuter MA; Dietz K
Urologe A; 2009 Jul; 48(7):740-7. PubMed ID: 19484215
[TBL] [Abstract][Full Text] [Related]
3. [Transurethral resection in prostate cancer, a radical procedure. Experience with 1017 cases].
Reuter MA; Corredera M; Epple W; Ungemach G; Verger ML; Dietz K
Arch Esp Urol; 2008; 61(1):13-26. PubMed ID: 18405024
[TBL] [Abstract][Full Text] [Related]
4. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
[TBL] [Abstract][Full Text] [Related]
5. Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.
Leyh-Bannurah SR; Liakos N; Oelke M; Wagner C; Schuette A; Fangmeyer B; Zinke J; Wasiri D; Mendrek M; Witt JH
J Urol; 2021 Aug; 206(2):308-318. PubMed ID: 33904761
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of incidental prostate cancer by radical transurethral resection of prostate cancer.
Morita M; Matsuura T
Clin Genitourin Cancer; 2013 Jun; 11(2):94-9. PubMed ID: 23137625
[TBL] [Abstract][Full Text] [Related]
7. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
8. Early postoperative outcome of bipolar transurethral enucleation and resection of the prostate.
Cho CL; Leung CL; Chan WK; Chu RW; Law IC
Hong Kong Med J; 2015 Dec; 21(6):528-35. PubMed ID: 26492836
[TBL] [Abstract][Full Text] [Related]
9. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
Küpeli S; Yilmaz E; Soygür T; Budak M
J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
[TBL] [Abstract][Full Text] [Related]
13. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
14. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
15. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.
Wei Y; Xu N; Chen SH; Li XD; Zheng QS; Lin YZ; Xue XY
Int Braz J Urol; 2016; 42(4):747-56. PubMed ID: 27564286
[TBL] [Abstract][Full Text] [Related]
16. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic radical prostatectomy after previous transurethral resection of prostate using a catheter balloon inflated in prostatic urethra: Oncological and functional outcomes from a matched pair analysis.
Pastore AL; Palleschi G; Silvestri L; Leto A; Al-Rawashdah SF; Petrozza V; Carbone A
Int J Urol; 2015 Nov; 22(11):1037-42. PubMed ID: 26177871
[TBL] [Abstract][Full Text] [Related]
18. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
19. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer.
Flam TA; Peyromaure M; Chauveinc L; Thiounn N; Firmin F; Cosset JM; Bernard D
J Urol; 2004 Jul; 172(1):108-11. PubMed ID: 15201748
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
